We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.40 | -1.01% | 234.40 | 236.20 | 236.40 | 236.80 | 234.00 | 235.40 | 5,778,976 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 37.17 | 4.85B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/11/2023 17:57 | Trading update Tuesday | smcni1968 | |
18/9/2023 09:39 | How will the weight loss/diabetes reducing wonder drugs affect Convatec's insulin business? Novo Nordisk(who make such a drug) own 19% of Convatec and recently took their representative off the Convatec board.Curious! | brain smiley | |
12/5/2022 16:38 | ConvaTec Group plc issued an AGM trading update for the four months ended 30 April 2022 this morning. Group revenue increased by 4.1% on a reported basis, up 7.5% on a constant currency basis and up 6.0% on an organic basis. ConvaTec has made a good start to the year with good underlying growth in each of its four categories in line with expectations. ConvaTec also announced that it will be withdrawing from its hospital care activities and related industrial sales during the remainder of 2022. These low margin activities being exited generated $ 101 m of revenue in 2021. Given this phased exit of the hospital care and related industrial sales products, reported revenue in 2022 is expected to be approximately $ 20-30 m lower than 2021 and adjusted EBIT is expected to reduce by $3-5m. There is also expected to be a one-off adjusted P&L charge of approximately $55m, which will be incurred in 2022, and a cash cost of approximately $25m arising mainly in 2022. FY22 guidance is unchanged, management expect organic revenue growth of between 4.0% and 5.5% and a constant currency EBIT margin of at least 18%. Valuation is average, profitability is decent, growth relatively modest. The share price also lacks some momentum. CTEC is a share to monitor for now.... ...from WealthOracleAM | km18 | |
31/3/2022 10:17 | Buy recommendation in Shares Mag today ( when the share price was 221.9). | husbod | |
09/12/2021 15:14 | Moving on very light volume | justiceforthemany | |
24/11/2021 14:07 | Strong chance of M&A here | justiceforthemany | |
30/7/2021 14:05 | Gross overreaction to the results - seems to be par for the course atm. | husbod | |
30/7/2021 14:05 | It's decent result to me. Buy opportunity? | gemmaqiu12 | |
06/4/2021 15:47 | Seems ripe for a takeover. | justiceforthemany | |
16/3/2021 20:46 | Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast last week and part of our discussion includes CTEC which we both see as a decent and solid Long-Term Hold kind of Stock. As always we also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. Specific topics in this one include the risks of anonymous Twitter Accounts and the devious tricks the ‘owners’ get up to, and we give examples of our own Trades and how we have Scaled in and Scaled out etc. Anyway, if you use Youtube, Apple, Audioboom, Overcast, Google+ or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 44) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, with the intent being that it is like you are eavesdropping on us having a chat down the local boozer (we can dream !!). Cheers, WD @wheeliedealer | thewheeliedealer | |
23/12/2020 12:15 | CTEC is one of Shares magazine top picks for 2021. In brief - the business is looking healthier after rectifing earlier mistakes and earnings growth is back on the menu | robow | |
28/10/2020 09:25 | No news in the court case that Scapa (SCPA) brought against Convatec? | marmar80 | |
31/5/2020 13:12 | Indeed, although I feel it may lose out to Kingfisher in the final furlong. The top four to replace the losers highlighted in The Observer are AVST,GVC,HSV and KGF at the moment although it is close between the latter and CTEC (I think all the others are safer bets). Review actually takes place at the close on Tuesday and changes become confirmed on Monday 22nd June. The following site is an excellent reference point for this: NB: All five might go in if ITV loses a bit more ground in the next three days. | doubleorquits | |
31/5/2020 12:56 | Getting some coverage about FTSE100 changeover, CTEC could move up on Fridayhttps://www.th | hootstox | |
12/5/2020 14:25 | 120 million share placing today. | brain smiley | |
03/5/2020 09:02 | Bubloo, they also do quite a bit of manufacturing in Belize as well | nickthe saint | |
30/4/2020 13:14 | bubloo, no i think they manufacture in Deeside UK | nickthe saint | |
28/2/2020 10:58 | For the pessimists...… | cottlet | |
27/2/2020 14:04 | Seems like an excellent appointment and the market certainly seems to think so.Reckon he would have had a look at the company before agreeing to take up the position so altogether a positive signal methinks. | husbod | |
26/2/2020 23:02 | does convatec source from china | bubloo | |
10/1/2020 16:31 | Always nice to see a non executive buying and a reasonable chunk - I assume the good doctor is not so wealthy that she can happily chuck away 20k or so.Happy to hold.You still here NYBoy? | husbod | |
05/1/2020 22:17 | more to go here? | smcni1968 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions